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We put forward the recommendation that more effort be made to align global vision-related 
research efforts with the causes of global blindness. With cataract accounting for more than one 
third of the burden of blindness, we think it reasonable that commensurate attention be paid to 
investigations into solutions to this situation. 
Mr Lavin presents the argument that we don’t need more research; the solutions are already known 
- they just need funding. Certainly, the very low prevalence of cataract blindness in high income 
countries,(1) and the strong positive association between Gross National Income of a country, and 
the Cataract Surgical Rate (CSR)(2) clearly demonstrates that there are macro-economic solutions to 
cataract blindness. Cataract surgery in blind patients has been proven to alleviate poverty,(3) hence 
a positive economic feedback loop would be created. It is possible in theory that rich people could 
fund the treatment of the majority of global cataract blindness, either directly or through taxation 
mediated public spending on health. However, this opportunity has been present for the past few 
decades(4) without being taken up. 
The problem of cataract blindness is not the lack of an efficacious intervention that could eliminate 
cataract blindness if global economic circumstances and corrupt human behaviour were different. 
What we advocate is that efforts are expended to identify effective, scalable and sustainable 
strategies – be they macro-economic, micro-economic, technological or administrative - that 
produce a CSR high enough, and sufficiently equitably accessible, to deal with incident cases of 
blinding cataract.  This will require implementation and health systems research and strategies that 
address the maldistribution of human resources for eye health,(5) integrate eye health into public 
health policy and financing arrangements, eliminate inequity,(6) and improve quality. 
If any billionaire philanthropists wish to prove us wrong, we would be delighted. But in their 
absence, we feel that global research efforts – which will to a large extent be reflected in funding – 
be directed proportionately at finding effective solutions to the leading causes of global blindness.  
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